Production (Stage)
D
REGENXBIO Inc. RGNX
$10.10 -$0.03-0.30% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 111.88% 14.11% -12.47% 16.33% -0.70%
Total Depreciation and Amortization -1.69% 1.57% -2.22% -3.09% -3.58%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 84.93% -56.95% 20.61% -36.91% 38.28%
Change in Net Operating Assets 40.79% 92.07% 250.37% 50.52% -188.44%
Cash from Operations 206.34% 22.01% 10.88% 17.96% -36.05%
Capital Expenditure 5.10% -230.98% 31.22% 14.90% 50.53%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 10.68% -18.25% 24,455.34% -98.50% -60.85%
Cash from Investing 11.10% -19.87% 18,852.99% -102.03% -61.20%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1,102.63% -94.10% 235.42% -99.86% 63,486.60%
Repurchase of Common Stock -- -- -- 100.00% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 26.19% 32.37% -19.34% 14.42% 7.48%
Cash from Financing 25.14% 28.71% -14.95% -107.82% 1,109.24%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 7,884.38% 179.18% 97.92% -170.37% 518.46%